Reforming Canada’s Access to Medicines Regime (CAMR): Bill C-393 – Finding the Expeditious Solution

In February 2010, a varied group of legal experts on intellectual property law and access to medicines from North America, Africa and Europe were brought together at the UNDP headquarters in New York City to discuss inter alia whether the reforms proposed to Canada’s Access to Medicines Regime (CAMR) by Bill C‐393 are compliant with the applicable provisions of WTO law,

Download